Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00715026 · ClinicalTrials.gov registry record · Phase 4
Trilogy AB Acetabular Hip System Post Approval Study
A Phase 4 study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT00715026 is a Phase 4 study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 31 participants.
The verdict
NCT00715026, a Phase 4 study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment of the clinical performance of the Zimmer Trilogy AB Acetabular Hip System.
Interventions
- DEVICE Trilogy AB Acetabular Hip Implant System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00715026
The ClinicalTrials.gov registry entry for NCT00715026 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trilogy AB Acetabular Hip Implant System is the first listed.
NCT00715026 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00715026 about?
NCT00715026 is a clinical study titled "Trilogy AB Acetabular Hip System Post Approval Study". This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment of the clinical performance of the Zimmer Trilogy AB Acetabular Hip Sy...
What is the current status of trial NCT00715026?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2009-04. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00715026?
The interventions under investigation include: Trilogy AB Acetabular Hip Implant System (DEVICE).
Who is sponsoring clinical trial NCT00715026?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.